Drawing for LABGENIUS

USPTO serial 79277459

LABGENIUS

Reviewed by CopyMark Law Group

Reg. 6253510Status 700Renewal
Filing date
Status date
Registration date
Jan 26, 2021
Examiner
MASON, JARED MICHAEL
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LABGENIUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Patricia I. Reding

Patricia I. Reding Faegre Drinker Biddle & Reath LLP90 South Seventh Street2200 Wells Fargo CenterMinneapolis, MN 55402

Goods and services

ClassDescriptionStatusFirst use
042Research and development in the field of peptide and protein engineering; research and development in the fields of gene synthesis, DNA sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; research and development in the field of pharmaceuticals; research and development in the field of therapeutics; design, development and maintenance of robotic automation software in the fields of gene synthesis, DNA sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; design, development and maintenance of software in the fields of gene synthesis, DNA sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; design and development of pharmaceuticals using machine learning; drug development and discovery services; drug development services using machine learning; drug development services using robotic automation; scientific services for structure analysis, modification of antibodies, peptides and/or proteins; scientific services for the production of genetically-engineered antibodies, peptides and/or proteins for others, namely, scientific development services; scientific services for drug development and discovery; consulting services in the fields of biotechnology and pharmaceutical research; provision of information and data relating to research and development; scientific technical data analysis services; analysis and interpretation of scientific data using machine learning; platform as a service (PAAS) featuring computer software platforms for data collection, data analytics and data interpretation, for use in the fields of therapeutics, gene synthesis, DNA sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; software as a service (SAAS) services featuring software for data collection, data analytics and data interpretation, for use in the fields of therapeutics, gene synthesis, DNA sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and developmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 26, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 23, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 30, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 30, 2021FIMPFINAL DISPOSITION PROCESSED—
Apr 26, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 26, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 10, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 10, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 8, 2020GPNXNOTIFICATION PROCESSED BY IB—
Oct 21, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 21, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 21, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 1, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 16, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 16, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 16, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 7, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 7, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 7, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 16, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 15, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 15, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 17, 2020RFNTREFUSAL PROCESSED BY IB—
Mar 30, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 30, 2020RFRRREFUSAL PROCESSED BY MPU—
Mar 17, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 16, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 13, 2020DOCKASSIGNED TO EXAMINER—
Feb 11, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 6, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 30, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance